# Mayo Clinic Phage Program Biobank

> **NCT05314426** · — · ENROLLING_BY_INVITATION · sponsor: **Mayo Clinic** · enrollment: 100 (estimated)

## Conditions studied

- Bacteriophage Therapy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05314426
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2022-04-19
- **Primary completion:** 2027-04
- **Final completion:** 2027-04
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05314426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05314426, "Mayo Clinic Phage Program Biobank". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05314426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*